efavirenz has been researched along with Hallucinations in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bisaso, KR; Bisaso, KS; Ette, EI; Mukonzo, JK | 1 |
| Belcher, R; Marcangelo, M | 1 |
| Aklillu, E; Gustafsson, LL; Luzze, H; Mukonzo, JK; Nakasujja, N; Ogwal-Okeng, J; Okwera, A; Sebuwufu, D; Waako, P | 1 |
| Hinsch, MC; Husstedt, IW; Reichelt, D | 1 |
| Chonzi, P; Dhoro, M; Kadzirange, G; Masimirembwa, C; Ngara, B; Nhachi, C; Zvada, S | 1 |
| Orikiiriza, JT | 1 |
| López-Cortés, LF; Ramírez-Duque, N | 1 |
7 other study(ies) available for efavirenz and Hallucinations
| Article | Year |
|---|---|
Maximizing Knowledge Extraction From Patient-Reported Outcome Data Using Exposure-Outcome Item Response Modeling Approach: Understanding Efavirenz-Induced Central Nervous System Toxicity.
Topics: Alkynes; Benzoxazines; Central Nervous System; Cognitive Dysfunction; Computer Simulation; Cyclopropanes; Disease Progression; Drug Administration Schedule; Hallucinations; HIV Infections; Humans; Models, Psychological; Patient Reported Outcome Measures; Patient-Specific Modeling; Reverse Transcriptase Inhibitors; Severity of Illness Index; Sleep Wake Disorders; Symptom Assessment; Time Factors | 2020 |
Efavirenz precipitating hallucinations in a patient with an undetected psychotic prodrome: a call for better screening at the point of care.
Topics: Adult; Alkynes; Antipsychotic Agents; Benzoxazines; Cyclopropanes; Hallucinations; HIV Infections; Humans; Male; Mental Disorders; Point-of-Care Systems | 2017 |
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.
Topics: Adult; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cognitive Dysfunction; Constitutive Androstane Receptor; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Female; Gene Frequency; Hallucinations; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Memory Disorders; Mental Disorders; Prospective Studies; Rifampin; Sleep Arousal Disorders; Tuberculosis; Uganda | 2013 |
[Acute psychosis as a side effect of efavirenz therapy with metabolic anomalies: an important differential diagnosis of HIV-associated psychoses].
Topics: AIDS Dementia Complex; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Delusions; Diagnosis, Differential; Female; Hallucinations; Humans; Middle Aged; Psychoses, Substance-Induced | 2014 |
CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Alleles; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Benzoxazines; Body Weight; Case-Control Studies; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Interactions; Female; Hallucinations; Headache; Humans; Male; Models, Biological; Rifampin; Sex Characteristics; Sleep Wake Disorders; Tuberculosis; Zimbabwe | 2015 |
Rollout of efavirenz-based regimens in option B+ in the prevention of mother-to-child transmission programs: challenges and lessons learned from a postexposure prophylaxis experience.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Child; Cyclopropanes; Female; Hallucinations; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Post-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors | 2016 |
[Neuro-psychiatric adverse effects associated with efavirenz].
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Catatonia; Cyclopropanes; Female; Hallucinations; Humans; Male; Oxazines; Reverse Transcriptase Inhibitors | 2006 |